Pfisterer, Thomas

Board of Directors

Thomas Pfisterer

Non-Executive Director

Thomas Pfisterer has served as a member of the board of directors of ADC Therapeutics since October 2016, having served in an observer role since the initial investment of the WILD Family Office in September 2015.

Mr. Pfisterer has been heading the Direct Investments activities of the WILD Family Office since the beginning of 2015. He joined the Family Office following the sale of WILD Flavors GmbH, one of the world’s leading suppliers of natural ingredients to the food and beverage industry, for which he served as Head of Strategic Development directing the company’s global M&A activities since October 2011.

Previously, Mr. Pfisterer worked in the investment banking division of Morgan Stanley Bank AG in Frankfurt, focusing on M&A and capital market transactions for German healthcare clients.

Mr. Pfisterer holds a Master in Finance (MPhil) from Cambridge University, as well as a Bachelor in Economics (B.A. HSG) and a Bachelor in Business Administration (B.A. HSG), both from University of St. Gallen.